Model validation confirms variable relative biological effectiveness and elevated periventricular sensitivity after

Martina Palkowitsch1, Larissa S Kilian2, Fabian Hennings1

  • 1OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany.